Cure My Disease

Don't miss your cure!

 Log in / Sign up

Depression genetics study tracks patients for 5 years to unlock clues

NCT ID NCT07078227

Recruiting now Knowledge-focused Sponsor: Region Skane Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 415 people with difficult-to-treat depression for 5 years after they joined an earlier genetics study. Researchers will review medical records and registry data to see how patients' depression changes over time, including suicide attempts and treatment responses. The goal is to find patterns and genetic markers that could improve long-term care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better predict long-term outcomes and personalize treatment for people with hard-to-treat depression.
What could go wrong
This is an observational follow-up study, not a treatment trial. It may not lead to immediate changes in care, and results depend on medical record accuracy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANHEDONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anhedonia Depression depressive disorder personality disorder Personality Disorders psychiatric disorder Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANHEDONIA CYP2D6 POLYMORPHISM DEPRESSION PERSONALITY DISORDERS PSYCHIATRIC DIAGNOSIS SUICIDE, ATTEMPTED

Contacts and locations

Locations

  • Psychiatry Reserach Unit

    ACTIVE_NOT_RECRUITING

    Lund, 221 85, Sweden

  • Research Unit, Office of Psychiatricy, habilitation and technical aid

    RECRUITING

    Lund, 221 85, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.